By suppressing chronic inflammation and immune dysfunction, this Nrf2 activator has also been shown to attenuate osteoclast production[288] and nonalcoholic steatohepatitis (NASH)[289]. This evidence concerns the gene NFE2L2 and metabolic dysfunction-associated steatohepatitis.